BPDCN

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

BPDCN
Dec 10, 2024, 14:00 | Blog
Naveen Pemmaraju: State-of-the-art review of BPDCN
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 6, 2024, 16:54 | Insight
Naveen Pemmaraju: How I treat Blastic Plasmacytoid Dendritic Cell Neoplasm
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Dec 2, 2024, 22:34 | Blog
Naveen Pemmaraju: ASH Hematology Session on Patient Care, Research and Education on Rare Disease
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 22, 2024, 14:36 | Opinion
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN International…
Nov 16, 2024, 09:15 | Blog
Naveen Pemmaraju: Current and Future directions in CML
Naveen Pemmaraju, Professor and Director of BPDCN Program at the Department of Leukemia at the…
Nov 15, 2024, 13:56 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN…
Nov 11, 2024, 18:37 | Blog
Taha Al-Juhaishi: Our work on BPDCN led by Dr. Haripriya Andanamala
Taha Al-Juhaishi, Associate Program Director of Hematology and Oncology Fellowship at University of Oklahoma Health…
Oct 25, 2024, 12:34 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the BPDCN International…
Oct 23, 2024, 04:16 | Blog
Naveen Pemmaraju: Annual 5K Walk/Run for Dan’s House of Hope
Naveen Pemmaraju shared on Linkedin: ''Spectacular event and marvelous weather this AM spending time with…
Oct 11, 2024, 17:33 | Insight
Naveen Pemmaraju: Blastic Plasmacytoid Dendritic Cell Neoplasm treatment with focus on SCT
Naveen Pemmaraju shared a post about a recent paper titled "How I treat Blastic Plasmacytoid…
Oct 10, 2024, 13:09 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the…
Oct 3, 2024, 12:54 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: “Article of the Week Suggested by the…
Sep 22, 2024, 00:11 | Blog
Naveen Pemmaraju: Wonderful to spend time with our brilliant leukemia fellows
Naveen Pemmaraju shared the following on LinkedIn: “Thank you to Guillermo Garcia-Manero MD & Tapan…
Sep 21, 2024, 14:48 | Career
Naveen Pemmaraju receives the IACH 2024 Special Achievement Award
The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL,…
Sep 19, 2024, 11:07 | Insight
Article of the Week, Suggested by the BPDCN International Registry
Immune Oncology Research Institute shared a post on LinkedIn: "Article of the Week Suggested by…
Sep 2, 2024, 16:02 | Blog
Naveen Pemmaraju: Fantastic venue with mix of pre-clinical and clinical presentations focused on novel pathways in heme malignancies
Naveen Pemmaraju shared on LinkedIn: “I recently gave an invited faculty talk at ISEH -…
Aug 24, 2024, 12:38 | Societies
Naveen Pemmaraju: Wonderful to kick-off The MPN Workshop of The Carolinas
Naveen Pemmaraju shared on LinkedIn: "Wonderful to kick-off today with my dear friend and colleague,…
Aug 12, 2024, 13:46 | Blog
Naveen Pemmaraju: The New WHO Classification of Tumors book 5th Edition is now out
Naveen Pemmaraju posted on LinkedIn: "It’s now here! The New WHO Classification of Tumors book…
Aug 11, 2024, 04:37 | Insight
Naveen Pemmaraju: Proud to be a part of the BPDCN chapter in the new WHO Book
Naveen Pemmaraju shared on X: "It’s here! Out now hot off the press! The new…
Jul 30, 2024, 07:14 | Blog
Naveen Pemmaraju: Superb clinic and research teams working together in Team Pemm clinic
Naveen Pemmaraju shared a post on X: "Superb clinic and research teams working together in…
Jul 24, 2024, 06:20 | Blog
Naveen Pemmaraju: Co-chairing the inaugural International Workshop on MPN24 meeting
Naveen Pemmaraju shared on LinkedIn: "I recently had the opportunity to co-chair with Prof Claire…
Jul 20, 2024, 12:06 | Blog
Andrew Lane: Powerful segment produced by Medical Stories on one of my brave patients at Dana-Farber with BPDCN
Andrew Lane, Associate Chief of Division of Hematologic Neoplasia at Dana-Farber Cancer Institute, shared a post…
Jul 15, 2024, 06:09 | Insight
Naveen Pemmaraju: Superb talk on developing immune-targeting agents in AML
Naveen Pemmaraju shared on X: "Absolutely superb talk by Dr Yasmin Abaza at AML-ALL US…
Jul 13, 2024, 09:41 | Insight
IMMONC - Immune Oncology Research Institute's Experience in Advancing Clinical Cancer Research in Armenia
Cancer affects people across the world regardless of their socioeconomic status. However, low- and middle-income…
Jun 19, 2024, 01:07 | Blog
Naveen Pemmaraju: Completely Amazed by the art exhibits my first time at Reina Sofia and Thyssen museums
Naveen Pemmaraju shared on X: "Completely Amazed by the art exhibits my first time at…
Jun 18, 2024, 10:27 | Insight
Naveen Pemmaraju: Our brand new MPN state-of-the-art review paper
Naveen Pemmaraju shared on LinkedIn:         . "Super excited to share our brand…
Jun 16, 2024, 14:10 | Insight
Naveen Pemmaraju: TRANSFORM-1 results randomized Phase 3 clinical trial at EHA24
Naveen Pemmaraju shared on X: "Honored to present at EHA24 today the TRANSFORM-1 results from…
May 31, 2024, 10:21 | Blog
Naveen Pemmaraju: HemeDreamTeam at our MDACC Cancer Network Partner led by Dr Summet Bhatia
Naveen Pemmaraju shared on X: "Wonderful to see the dedicated HemeDreamTeam at our MDACC Cancer…
May 16, 2024, 12:04 | Blog
Naveen Pemmaraju: Amazing job speaking in the Fellows’ Roundtable at HOPLive24
Naveen Pemmaraju shared on LinkedIn: "Shout out to our outstanding MD Anderson Cancer Center medical…
May 1, 2024, 10:13 | Blog
Jayastu Senapati: Talk on Blastic plasmacytoid dendritic cell neoplasm
Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center shared a post on…
Apr 27, 2024, 09:11 | Blog
Naveen Pemmaraju: Thanks to Dr G. Garcia-Manero for inviting me to speak today about 'BPDCN: State-of-The-Art Updates 2024'
Quoting Naveen Pemmaraju on X/Twitter: "Special thanks to Dr G. Garcia-Manero for inviting me to…
Apr 20, 2024, 07:12 | Insight
Naveen Pemmaraju: Superb clinic team discussions and new ideas
Naveen Pemmaraju shared on X/Twitter: “Superb clinic team discussions and new ideas and patient-centered brainstorming for…
Apr 19, 2024, 20:20 | Drugs
This new review article is all about Tagraxofusp for BPDCN - ACS Journal Cancer
ACS Journal Cancer recently shared on X: "This new review article from Wei Ying Jen,…
Apr 15, 2024, 12:42 | Blog
Naveen Pemmaraju: Our collaboration with Dr Gabe Mannis and team in BPDCN
Naveen Pemmaraju shared a post on X: "Our collaboration with/Dr Gabe Mannis and team with…
Apr 15, 2024, 02:40 | Insight
Naveen Pemmaraju: Check out our exciting growing international BPDCN collaboration with Dr. Gevorg Tamamyan and Armenia
Quoting Naveen Pemmaraju on X/Twitter: "Check out our exciting growing international BPDCN collaboration with Dr.…
Mar 28, 2024, 14:07 | Insight
Naveen Pemmaraju: Honored to work with and share our growing international collaboration with Gevorg Tamamyan and team in Armenia
Naveen Pemmaraju shared a post by Cancer Network on X/Twitter: "Honored to work with and…
Mar 27, 2024, 21:12 | Insight
Naveen Pemmaraju: Our new collaborative report CD38 and BCL2 guided therapy in BPDCN
Naveen Pemmaraju posted on X/Twitter: "Excited to share our interesting new collaborative report CD38 and BCL2…
Mar 24, 2024, 13:54 | Blog
Naveen Pemmaraju: Delighted to share my interview and discussion with Dr Neil Love on BPDCN
Naveen Pemmaraju shared on LinkedIn: "Delighted to share my interview and discussion with Dr Neil Love…
Mar 18, 2024, 15:32 | Blog
Naveen Pemmaraju: I was deeply honored to be an invited speaker at the prestigious 2nd Myeloid Malignancies Workshop in NYC at, Mt Sinai School of Medicine
Naveen Pemmaraju posted on LinkedIn: “Last week, I was deeply honored to be an invited…
Mar 11, 2024, 03:32 | Insight
The March issue of ONCOLOGY is available and ready to download - Cancer Network
Cancer Network shared on their X/Twitter: "The March issue of ONCOLOGY is available and ready…
Feb 24, 2024, 11:41 | Blog
Megan Murray Dupuis: Excited to see my mentor and friend giving a beautiful, sweeping talk on BPDCN
Megan Murray Dupuis, an Oncologist at Vanderbilt University Medical Center, shared on X/Twitter: "Excited to…
Feb 14, 2024, 18:37 | Blog
Naveen Pemmaraju: Important brainstorming sessions today with Team Pemm for new ideas in MPNSM & BPDCN!
Naveen Pemmaraju shared on X: “Important brainstorming sessions today with Team Pemm for new ideas…
Jan 31, 2024, 14:55 | Blog
BPDCN Awareness Day took place this week on January 23rd - The Video Journal of Hematological Oncology
The Video Journal of Hematological Oncology made the following post on X: “BPDCN Awareness Day took…
Jan 22, 2024, 16:27 | Insight
Nerses Ghahramanyan: BPDCN International Registry is growing rapidly, involving people from various continents
Nerses Ghahramanyan, Head of Adult Hematology and Chemotherapy Outpatient Department at Yeolyan Hematology and Oncology…
Dec 10, 2023, 19:52 | Blog
We spoke with Nerses Ghahramanyan on challenges that remain in the diagnosis and treatment of BPDCN - The Video Journal of Hematological Oncology
The Video Journal of Hematological Oncology, made the following post on Twitter: "ASH23 | We…
Nov 11, 2023, 17:29 | Positive
Naveen Pemmaraju: Thank you to all of our leukemia nurses- they are the best in the world!
Quoting Naveen Pemmaraju on X/Twitter: "Wonderful to be surrounded by so many outstanding colleagues in…
Oct 16, 2023, 18:19 | Blog
BPDCN Updates and Progress in 2023 - Naveen Pemmaraju
On OncoDaily we are starting lectures from the experts through the BPDCN Global Network and…
Oct 6, 2023, 17:11 | Insight
Amer Zeidan: How well does Allogeneic Hematopoietic Cell Transplantation (AlloHCT) work for Blastic Plasmacytoid Dendritic Cell Neoplasm BPDCNsm?
Amer Zeidan, recently tweeted: "How well does Allogeneic Hematopoietic Cell Transplantation (AlloHCT) work for Blastic…
Oct 4, 2023, 21:05 | Blog
Naveen Pemmaraju: Honored to be invited to speak on Updates in BPDCN at Soho Italy in Rome, Italy this week!
Naveen Pemmaraju, made the following post on Twitter: "Honored to be invited to speak on Updates…
Sep 14, 2023, 17:46 | Blog
Taylor Lab: Great cases and discussion with BPDCN master physicians, physician-scientists, hematopathologists and more!
Taylor Lab, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, recently shared on X/Twitter:…
Sep 2, 2023, 19:00 | Opinion
Naveen Pemmaraju: Please join us for a special episode of Heme Reports!
Naveen Pemmaraju, the Director of the Leukemia - Cancer Network at the MD Anderson Cancer Center,…
Jul 29, 2023, 18:50 | Blog
All my appreciation for Naveen Pemmaraju for being a world leader in the field of BPDCN (yes 123 field !) and MPN - Nitin Jain
All my appreciation for Naveen Pemmaraju for being a world leader in the field of…
Jun 14, 2023, 12:42 | Opinion
We should never stop our efforts to provide the right patient with the right medicine at the right time
According to Matthijs Van Meerveld, "The right medicine for the right patient at the right…
Jun 13, 2023, 17:24 | Insight
In 16 months, we have registered more cancer clinical trials in Armenia, than throughout all the years before that - Gevorg Tamamyan
Last year, on February 4th I was doing a presentation about the cancer clinical trials…
Jun 9, 2023, 02:54 | Insight
The field of BPDCN is rapidly evolving - Hagop Kantarjian
The field of BPDCN is rapidly evolving. Our new article by Dr. Pemmaraju highlights the…
All: 55 Posts: 1 - 100
Special Coverage